GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Experimental Therapeutics by targeting Spleen Tyrosine Kinase

$363,907
Ie-Ming Shih · Johns Hopkins University · R01 · FY2019 · CA

Regulation of Pancreatic Oncogenesis by the Gut Microbiome

$363,894
George Miller · New York University School Of Medicine · R01 · FY2019 · CA

Elucidating the Role of Perivascular Niche in Glioblastoma Invasion and Therapeutic Resistance at Single Cell Resolution using Biomimetic Tumor Microenvironment Models

$363,880
Mehdi Nikkhah · Arizona State University-Tempe Campus · R01 · FY2024 · NS

Molecular Pathology of Cancer

$363,876
Michael Emmert-Buck · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA

Project 2: Immunotherapy with CMP-001 intratumoral and nivolumab in melanoma

$363,864
Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2021 · CA

Project 3: Localized microneedle-directed combination immunotherapy for cSCC

$363,863
Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2021 · CA

Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients

$363,863
Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P50 · FY2021 · CA

Defining an acetyl-CoA sensing mechanism as a form of inter-organelle communication in cancer

$363,850
Kathryn Elaine Wellen · University Of Pennsylvania · R01 · FY2022 · CA

Local Regulation of Angiogenesis by Microenvironment

$363,825
Christopher S Chen · Boston University (Charles River Campus) · R01 · FY2021 · EB

Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms

$363,801
Katherine B Chiappinelli · George Washington University · R37 · FY2023 · CA

Regulation of Tumor Invasion and Metastasis by Matrix Stiffness

$363,773
Jing Yang · University Of California, San Diego · R01 · FY2022 · CA

Regulation of Tumor Invasion and Metastasis by Matrix Stiffness

$363,773
Jing Yang · University Of California, San Diego · R01 · FY2025 · CA

Defining the effects of bortezomib on NK cell activation in cancer

$363,750
Anil Shanker · Meharry Medical College · SC1 · FY2013 · CA

Roles of proinflammatory chemokines linking obesity and breast cancer

$363,750
Deok-Soo Son · Meharry Medical College · SC1 · FY2017 · CA

Defining the effects of bortezomib on NK cell activation in cancer

$363,750
Anil Shanker · Meharry Medical College · SC1 · FY2015 · CA

Roles of proinflammatory chemokines linking obesity and breast cancer

$363,750
Deok-Soo Son · Meharry Medical College · SC1 · FY2016 · CA

Defining the effects of bortezomib on NK cell activation in cancer

$363,750
Anil Shanker · Meharry Medical College · SC1 · FY2016 · CA

Inhibition of angiogenesis by thrombospondin-1 (A2)

$363,727
John W Lawler · Beth Israel Deaconess Medical Center · R01 · FY2010 · CA

Tumor Cell-Intrinsic/Extrinsic Mechanisms Underlying Myeloma Disease Progression

$363,713
Diane F Jelinek · Mayo Clinic Rochester · R01 · FY2018 · CA

Tumor Cell-Intrinsic/Extrinsic Mechanisms Underlying Myeloma Disease Progression

$363,713
Diane F Jelinek · Mayo Clinic Rochester · R01 · FY2015 · CA

Monocyte promotion of therapy resistance by immune and non-immune mechanisms

$363,713
Yi Lin · Mayo Clinic Rochester · R01 · FY2016 · CA

Tumor Cell-Intrinsic/Extrinsic Mechanisms Underlying Myeloma Disease Progression

$363,713
Diane F Jelinek · Mayo Clinic Rochester · R01 · FY2016 · CA

Tumor Cell-Intrinsic/Extrinsic Mechanisms Underlying Myeloma Disease Progression

$363,713
Diane F Jelinek · Mayo Clinic Rochester · R01 · FY2017 · CA

Monocyte promotion of therapy resistance by immune and non-immune mechanisms

$363,713
Yi Lin · Mayo Clinic Rochester · R01 · FY2020 · CA

Re-purposing Oncolytic Virotherapy to Re-invigorate CAR T Cell Therapy for Solid Tumors.

$363,713
Richard G Vile · Mayo Clinic Rochester · R01 · FY2025 · CA